ALERS — Eurobio Scientific SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for Eurobio Scientific SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	FAS	FAS	FAS	FAS	FAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	189	185	153	130	155
Cost of Revenue
Gross Profit	110	102	70.9	61.2	71.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	108	114	122	121	142
Operating Profit	81.2	71.2	30.3	8.7	12.1
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	80.9	71.3	29.7	6.98	6.28
Provision for Income Taxes
Net Income After Taxes	73.5	60.5	24.9	4.83	4
Net Income Before Extraordinary Items
Net Income	73.5	60.5	24.9	4.83	4
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	73.5	60.5	24.9	4.83	4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.78	5.74	2.77	1.09	0.944
Dividends per Share